Prescribing lithium for bipolar disorder: are we too scared?

Doctor writing prescription

Deenan Edward and Suhana Ahmed summarise a Scottish study of prescribing for bipolar disorder between 2009-2016, which identified a clear trend towards decreasing lithium use.

[read the full story...]

How can digital technology help close the mortality gap for people with severe mental illness?

shutterstock_134284016

Lina Gega from the Closing the Gap Network explores a recent review of digital technology for health promotion, which looks at opportunities to address excess mortality in people living with severe mental illness.

[read the full story...]

Racial disparities in bipolar disorder diagnosis and treatment: time to talk about racism

pavel-anoshin-704058-unsplash

Syeda Akther writes her debut elf blog on a recent review looking at racial disparities in bipolar disorder treatment and research. She argues that we need to start having serious conversations about racism that go beyond unconscious bias.

[read the full story...]

Pregnancy and bipolar disorder: international prescribing consensus?

Pregnant woman with drugs

Dean Connolly looks at an international study which asks: Is there consensus across evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?

[read the full story...]

Can interventions help to improve social functioning in youth at risk of psychosis?

jordan-mcqueen-1290-unsplash

Carla McEnery summarises a systematic review and meta-analysis of interventions and social functioning in youth at risk of psychosis.

[read the full story...]

Lifestyle training for schizophrenia: STEPWISE fails to make a difference

clem-onojeghuo-1169553-unsplash

Ben Janaway writes his debut elf blog on the STEPWISE RCT which is out today in the British Journal of Psychiatry: Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis.

[read the full story...]

Genetics of depression: understanding risk and improving treatment

dr-gauchet

Douglas Levinson on a genome-wide meta-analysis of depression in 807,553 individuals, which identifies 102 independent variants relating to the genetics of depression.

[read the full story...]

Preventing psychosis: no one intervention is better than the rest

candice-picard-1111655-unsplash

A group of UCL Mental Health Masters students summarise a recent network meta-analysis that highlights a lack of evidence about specific interventions for preventing psychosis.

[read the full story...]

Behavioural and psychological symptoms of dementia: GPs’ perspective on management

woman-65675_1920

Marie Crabbe presents the findings of a mixed-methods systematic review, which looks at General Practitioners’ knowledge, attitudes and experiences of managing behavioural and psychological symptoms of dementia.

[read the full story...]

Medical cannabis for mental illness: current use is not supported by research #MHQT

sharon-mccutcheon-798864-unsplash

As we prepare for our Cannabis #MHQT event on Wed 26 Sep, Luke Sheridan Rains dissects a narrative review that asks: Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

His answer is that current evidence does not support the use of medical cannabis for mental illnesses such as anxiety or depression.

[read the full story...]